Scafetta R, Troiano R, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Donato M, Foderaro S, Venuti F, Vilardi FA, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, Cesa A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Garrone O, Domati F, Piombino C, Lisa FSD, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, Lisi D, Orsaria P, Grasso A, Ippolito E, Ramella S, Visani L, Livi L, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Bonomo MV, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri MA, Giorgi U, Vici P, Toss A, Ruatta F, Laurentiis M, Villa F, Berardi R, Minelli M, Altomare V, Vernieri C, Curigliano G, Chirco A, D'Alessandro S, Vincenzi B, Tonini G, Santini D, Pantano F

Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study.

Eur J Cancer 2026; 116703. doi: 10.1016/j.ejca.2026.116703

Scafetta R, Donato M, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Troiano R, Foderaro S, Venuti F, Vilardi FA, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, La Cesa A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Chirco A, D'Alessandro S, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Rossino MG, Domati F, Piombino C, Di Lisa FS, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, De Lisi D, Orsaria P, Grasso A, Ippolito E, Ramella S, Visani L, Bertini N, Bonaparte I, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Bonomo MV, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri MA, De Giorgi U, Vici P, Toss A, Garrone O, De Laurentiis M, Villa F, Berardi R, Minelli M, Altomare V, Vernieri C, Curigliano G, Vincenzi B, Tonini G, Santini D, Pantano F

Comparative real-world progression free survival of CDK4/6 inhibitors in HR+/HER2- breast cancer patients with bone metastases.

Oncologist 2026; . doi: 10.1093/oncolo/oyag146

Pseftogas A, Bordini J, Gavriilidis G, Frenquelli M, Campanella A, Rovida A, Morello G, Gerousi M, Theodosiou E, Fragkouli SC, Vasileiou V, Sklaviadis T, Dafou D, Mosialos G, Tripodo C, Psomopoulos F, Winkler TH, Stamatopoulos K, Ghia P, Xanthopoulos K

The deubiquitinase activity of CYLD is required for B cell differentiation.

Cell Death Dis 2026; . doi: 10.1038/s41419-026-08555-x

Becherini C, Blondeaux E, Delucchi V, Visani L, Kim HJ, Coussy F, Bernstein-Molho R, Di Meglio A, Hilbers FS, Pogoda K, Kwong A, Agostinetto E, Baten A, Bajpai J, Balmana J, Moore HCF, Partridge AH, Rousset-Jablonski C, Phillips KA, Toss A, Renaud T, Ferrari A, Peccatori FA, Sanchez L, Paluch-Shimon S, Cui W, Wong SM, Ryu JM, Fruscio R, Lee MK, Vernieri C, Matikas A, Couch FJ, De Marchis L, Dieci MV, Aguilar-Y-Mendez D, Hwang SE, Rozenblit M, Can Güven D, Mrinakova B, Harbeck N, Sanchez-Bayona R, Boni L, Lambertini M, Meattini I

Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study.

Radiother Oncol 2026; 111523. doi: 10.1016/j.radonc.2026.111523

Tirtei E, Difilippo V, Divincenzo F, Asaftei SD, Ratto N, Piana R, Pellegrino P, Linari A, Papotti M, Mareschi K, Parlato C, Guarrera S, Minucci S, Rabusin M, Manzitti C, Prete A, Mercolini F, Luksch R, Meazza C, Parafioriti A, Tamburini A, Coccoli L, Mura R, Zecca M, Palmerini E, Ibrahim T, Peirone S, Penolazzi L, De Luna E, Cagnazzo C, Bombaci S, Ferrero I, Niclot AGSB, Proto CF, Spadea M, Quarello P, Marini E, Gizzi K, Fenoglio B, Livellara V, Di Gangi A, Puma N, Sironi G, Di Bernardo A, Cereda M, Fagioli F

Mapping Genomic Heterogeneity in Pediatric and Adolescent-Young Adult Sarcomas: Insights from the Italian SAR-GEN2016 and SAR-GEN_ITA Prospective Multicenter Trials.

Cancer Res Commun 2026; 857-872. doi: 10.1158/2767-9764.CRC-25-0697

Mazzoli G, Provenzano L, Dieci MV, Curigliano G, Giuliano M, Botticelli A, Lambertini M, Rizzo G, Pedersini R, Sirico M, La Verde N, Gennari A, Zambelli A, Toss A, Piras M, Giordano M, Tagliaferri B, Generali D, Sartori D, Fotia G, De Monte M, Ligorio F, Jacobs F, Armani G, Zurlo C, Menichetti A, Griguolo G, Faso V, Schianca AC, Munzone E, Marra A, Chiappe E, Scagnoli S, Pisegna S, Capasso C, De Angelis C, Arpino G, Criscitiello C, Guarneri V, Pruneri G, Mariani L, Vernieri C

Effectiveness comparison of first-line CDK4/6 inhibitors in patients with hormone-positive HER2-negative advanced breast cancer according to tumor histology: a sub-analysis of the real-world, multicenter, Italian study PALMARES-2.

Breast 2026; 104692. doi: 10.1016/j.breast.2026.104692

Dauccia C, Bruzzone M, Arecco L, Blondeaux E, Sirico M, Gerosa R, Franzoi MA, Brandão M, Perrone L, Pedrazzoli P, Desmedt C, Di Cosimo S, Vernieri C, Collet L, Lambertini M, de Azambuja E, Agostinetto E

Association between body mass index and risk of breast cancer according to breast cancer subtypes: A systematic review and meta-analysis.

Breast 2026; 104710. doi: 10.1016/j.breast.2026.104710

Siciliano MC, Bertolazzi G, Glaser S, Granai M, Lori C, Boccacci R, Yellapragada SV, Vannucchi M, Ferrara D, Dreval K, Marafioti T, Quintanilla-Martinez L, Falko F, Morin RD, Bellan C, Ott G, Tripodo C, Siebert R, Lazzi S, Mbulaiteye SM, Leoncini L

Immune disparities in the TME of EBV+ and EBV- BL: role of ROS generation pathways and platelet activation.

Blood Adv 2026; . doi: 10.1182/bloodadvances.2025018518

Marchesi S, Guidolin C, Massey AE, Lemahieu G, Lavagnino Z, Beznoussenko GV, Mironov AA, Green BJ, Allievi E, Martini E, Magni S, Ghisleni A, Lomazzi C, Benvenuto AF, Schertel A, van Faassen DA, Freddi S, Bertalot G, Parazzoli D, Maiuri P, Mapelli M, Pece S, Sigismund S, Gauthier NC, Cavalcanti-Adam EA, Cartagena-Rivera AX, Giavazzi F, Scita G, Disanza A

Mechanisms of active wetting and fluidification in epithelial cell collectives.

Nat Mater 2026; . doi: 10.1038/s41563-026-02553-2

Fusilier Z, Clément A, Simon F, Calvente I, Jean-Marie R, Mathieu M, Calmettes V, Piastra-Facon F, Quintana-Perez Y, Clement JG, Crestey L, Lumineau E, Henninger R, Tonani M, Manriquez V, Lacerda Mariano L, Bensaid L, de Villemagne P, Piaggio E, Semetey V, Coscoy S, Martini E, Scita G, Gelly JC, Ivaska J, Isambert H, Goudot C, Pierobon P, Lennon-Duménil AM, Moreau HD

Macrophages restrict tumor immune infiltration by controlling collagen topography.

Sci Immunol 2026; eadw8291. doi: 10.1126/sciimmunol.adw8291

Bolli E, Wirapati P, Hicham M, Xie Y, Siwicki M, Duval F, Goubet AG, Kiss M, Zitti B, Zwahlen T, Mcdowell S, Bill R, Angerani S, Engblom C, Anderson S, Jiang A, Hartley O, Sykes DB, Jankovic M, Fournier N, Gunzer M, Tarussio D, Tissot S, Sadow PM, Faquin WC, Sade-Feldman M, Weissleder R, Pai S, Mercier F, Manguso R, Pittet MJ

CCL3 is produced by aged neutrophils across cancers and promotes tumor growth.

Cancer Cell 2026; 624-640.e12. doi: 10.1016/j.ccell.2026.01.006

Lonardi S, Cancila V, Morello G, Varano G, Balzarini P, Pellegrini V, Albertini E, Giampaolo S, Pietrini I, Thanasi H, Sindaco P, Piazza F, Manni S, Lorenzini D, Pruneri G, Dei Tos AP, Ponzoni M, Facchetti F, Pizzi M, Lorenzi L, Tripodo C, Casola S

RAG1/2 expression in IGH-switched follicular lymphoma associated with transformation to high-grade B-cell lymphoma.

Leukemia 2026; . doi: 10.1038/s41375-026-02896-4

Brevi A, Lorenzoni M, Caputo S, Yamada Y, Grioni M, Cogrossi LL, Martinez-Vidal L, Cassina V, Cipria D, Venegoni C, Zordan P, Matafora V, Tascini AS, Tenace NP, Campanile R, Cucchiara V, Pinna V, Jachetti E, Galli R, Bachi A, Colecchia M, Briganti A, Freschi M, Mantegazza F, Lombardo A, Demichelis F, Beltran H, Alfano M, Bellone M

Intercepting YAP Activation in Prostate Cancer Blocks Neuroendocrine Progression.

Cancer Res 2026; . doi: 10.1158/0008-5472.CAN-25-2704

Vinciguerra M, El Kharef C, Bruhn C, Falbo L, Milanese C, Audano M, Beznoussenko GV, Mironov AA, Delia D, Foiani M, Mastroberardino PG, Mitro N, Costanzo V

Targeting the FNIP2-SERCA2b axis improves metabolic and mitochondrial defects in Ataxia Telangiectasia.

Cell Death Dis 2026; . doi: 10.1038/s41419-026-08507-5

Martelli G, Barretta F, Muzi C, Listorti C, Pilotta F, Maugeri I, Osio C, Bonfili D, Vernieri C, Bianchi G, Pruneri G, Folli S, Scaperrotta G, Baili P, Miceli R, Ferraris C

Sentinel Node Biopsy Alone Versus Sentinel Node Biopsy Plus Axillary Dissection in cT2 cN0/1 Breast Cancer After Neoadjuvant Chemotherapy: 15-Year Results of a Prospective Interventional Study.

Ann Surg Oncol 2026; 2255-2266. doi: 10.1245/s10434-025-18673-z

Kaivola J, Punovuori K, Chastney MR, Abdo H, Follain G, Mathieu M, Joshi O, Miroshnikova YA, Krautgasser F, Di Franco J, Conway JRW, Held S, Bertillot F, Hagström J, Mäkitie A, Irjala H, Ventelä S, Hamidi H, Scita G, Cerbino R, Wickström SA, Ivaska J

Restoring the tumour mechanophenotype of vocal fold cancer reverts its malignant properties.

Nat Mater 2026; . doi: 10.1038/s41563-025-02473-7

Giuli MV, Mancusi A, Natiello B, Di Cristofano S, Reali R, Pignataro MG, D'Andrea D, Di Magno L, Nicoletti C, Giorgi A, Macone A, Camerini S, Casella M, Peruzzi G, Zema S, Canettieri G, Tomao F, Palaia I, Pernazza A, Rustighi A, Palermo R, Raimondo D, Monti A, Doti N, d'Amati G, Del Sal G, Screpanti I, Talora C, Bellavia D, Checquolo S

Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.

J Exp Clin Cancer Res 2026; . doi: 10.1186/s13046-026-03658-x

Avolio M, Leto SM, Sassi F, Lupo B, Grassi E, Catalano I, Zanella ER, Vurchio V, Cottino F, Tsantoulis PK, Lazzari L, Luraghi P, Ferri M, Galimi F, Berrino E, Bellomo SE, Viviani M, Sogari A, Mauri G, Tosi F, Cruciani F, Sartore-Bianchi A, Siena S, Borghi F, Torri V, Élez E, Tabernero J, Nieva M, Montagut C, Tarazona N, Cervantes A, Tejpar S, Bardelli A, Marchiò C, Marsoni S, Bertotti A, Trusolino L

The Molecular and Functional Landscape of Resistance to FOLFIRI Chemotherapy in Metastatic Colorectal Cancer.

Cancer Discov 2026; 270-295. doi: 10.1158/2159-8290.CD-24-0556

Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA, Ragoussis J, Amadori D, Harris AL, Kang Y

Editorial Expression of Concern: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Nat Med 2026; 768. doi: 10.1038/s41591-026-04242-8

Terraneo F, Ceccon M, Sapkota O, Zheng T, Brizioli M, Dello Stritto A, Cummings S, Codispoti S, Ossolengo G, Orsenigo F, Magni S, Gottinger A, Mattevi A, Fuxreiter M, Fawzi NL, Lottersberger F, Giavazzi F, d'Adda di Fagagna F

The glycine-arginine-rich motif of 53BP1 modulates RNA interactions necessary for its liquid-liquid phase separation during DNA Damage Response.

bioRxiv 2026; . doi: 10.64898/2026.01.30.702603

Pisegna S, Scagnoli S, Gentile G, Chiavassa A, Caputo R, De Laurentiis M, Curigliano G, Lambertini M, Pantano F, Orlandi A, Palazzo A, Paris I, Vernieri C, Tedesco B, Giampaglia M, Palleschi M, Ballatore Z, Alesini D, D'Auria G, Fabbri MA, Rossi L, Fiscon G, Marchetti P, Fabi A, Botticelli A

Clinical characteristics and drug-drug interactions in human epidermal growth factor receptor 2-positive breast cancer treated with trastuzumab deruxtecan: real-world data from the DE-REAL study.

Oncologist 2026; . doi: 10.1093/oncolo/oyaf402

Zitti B, Duval F, Wirapati P, Hicham M, Xie Y, Oh J, Hoelzl J, Meiser P, Varrone M, Peterson HM, Cianciaruso C, Bill R, Bayerl F, Bolli E, Goubet AG, Kiss M, McDowell S, Cheng P, Celestini D, Terzic J, Zwahlen T, Alouche N, Zouggari N, Tarussio D, Tissot S, Nunes-Hasler P, Mino-Kenudson M, Lanuti M, Faquin WC, Sadow PM, Tille JC, Intidhar Labidi-Galy S, Garris CS, Hugues S, Petrova TV, Ludewig B, Quezada S, Luther S, Mempel TR, Ciriello G, Pai SI, Michielin O, Böttcher JP, Weissleder R, Pittet MJ

Positioning and reversible suppression of CCR7+ dendritic cells in perivascular tumor niches shape cancer immunity.

Immunity 2026; 161-176.e12. doi: 10.1016/j.immuni.2025.11.020

Vittorelli N, Gómez-Muñoz C, Andriushchenko I, Ollivier L, Agier N, Delmas S, Corbeau Y, Achaz G, Cosentino Lagomarsino M, Liti G, Llorente B, Fischer G

Repeated losses of self-fertility shaped heterozygosity and polyploidy in yeast evolution.

Proc Natl Acad Sci U S A 2026; e2525679123. doi: 10.1073/pnas.2525679123

Arnoult C, Attardi LD, Batsheva K, Blandino G, Burns KH, Del Sal G, Kirsch DG, Lane DP, Levine AJ, Lozano G, Malkin D, Melino G, Oren M, Prives C, Schramek D

The legacy of a gentleman scientist: Pierre Hainaut.

Cell Death Differ 2026; 1-2. doi: 10.1038/s41418-025-01586-5

Laue K, Pozzi S, Zerbib J, Bertolio R, Eliezer Y, Cohen-Sharir Y, Winkler T, Caputo M, Ricci AA, Adler L, Khoury R, Longobardi G, Slutsky R, Leikin-Frenkel AI, Ovadia S, Lange K, Rustighi A, Piazza S, Sacconi A, Magesh RY, Keller FN, Berthelet J, Schäffer A, Saad R, Israeli Dangoor S, Szczepanowska K, Barshack I, Liao Y, Malitsky S, Brandis A, Broggini T, Czabanka M, Shi W, Merino D, Watson EV, Blandino G, Erez A, Ashery-Padan R, Medyouf H, Bertero L, Del Sal G, Satchi-Fainaro R, Ben-David U

p53 inactivation drives breast cancer metastasis to the brain through SCD1 upregulation and increased fatty acid metabolism.

Nat Genet 2026; 116-131. doi: 10.1038/s41588-025-02446-1

Makkieh M, Passeri AA, Lazzari D, Marchesi S, Disanza A, Salem RKA, Bonacci F, Mazzella C, Martini E, Tonani M, Donati L, Bellini E, Abdo H, Pineau J, Magni S, Orsenigo F, Piel M, Fioretto D, Martino S, Mattarelli M, Scita G, Green BJ, Caponi S

Brillouin Microscopy of Breast tumor Spheroids On-a-Chip: Mechanical and Transcriptional Responses to Microfluidic-Induced Rapid Deformations.

Adv Sci (Weinh) 2026; e13153. doi: 10.1002/advs.202513153

Abdo H, Barzaghi L, Shen Y, Bellini E, Martini E, Magni S, Barozzi S, Orsenigo F, Parazzoli D, Beznoussenko GV, Franco JD, Krautgasser F, Kaivola J, Cinquanta M, Lazzarin A, Sigismund S, Ivaska J, Cerbino R, Scita G

De Novo Gene Transcription of Connexin Mediates Cytoplasmic Fluid Exchange and Flocking Transitions in Physiological and Cancerous Epithelial Systems.

Adv Sci (Weinh) 2026; e08648. doi: 10.1002/advs.202508648

Masud W, Russo L, Chapdelaine-Trépanier V, Hayward SB, He W, Cirò M, Mercurio C, Xu H, Ciccia A, Cuella-Martin R, Leuzzi G

A base editing resource for functional annotation of DNA repair variants in breast-derived cell models.

Front Cell Dev Biol 2026; 1714494. doi: 10.3389/fcell.2026.1714494

Esposito F, Capozzo I, Riccardi A, Gioia U, Modafferi S, Manfredi L, Colantoni A, Tavella S, Cabrini M, Iannelli F, di Lillo A, d'Adda di Fagagna F, Francia S

DROSHA, DICER, and damage-induced long ncRNA control BMI1-dependent transcriptional repression at DNA double-strand break.

Cell Rep 2025; 116605. doi: 10.1016/j.celrep.2025.116605

Anfuso B, Velnati S, Selvestrel D, Garlant C, Ferracci E, Baj G, Parisse P, Overi D, Bertolio R, Bulla R, Sonzogni A, Bramuzzo M, Casalis L, Cocomello N, Baratta F, Del Ben M, Giraudi P, Tiribelli C, Rosso N, Mastronardi M, Tarchi P, Pinamonti M, Zanconati F, de Manzini N, Gaudio E, Palmisano S, Bonazza D, Del Sal G, Carpino G, Chiacchiera F, Sorrentino G

An organotypic model of ductular reaction reveals a mevalonate-dependent vulnerability in reactive biliary cells.

Cell Rep 2025; 116681. doi: 10.1016/j.celrep.2025.116681

Miglietta F, De Graaf M, Vernieri C, Piacentini F, Cacciatore M, Botticelli A, Vingiani A, Fotia G, Nicolè L, Griguolo G, Giarratano T, Massa D, Pellegrini V, Schiavi F, Porra F, Fassan M, Pruneri G, Dei Tos AP, Guarneri V, Kok M, Dieci MV

Prognosis and Biological Characteristics of ER-Low Metastatic Breast Cancer: Results from a Multicenter Cohort and the TONIC Trial.

Clin Cancer Res 2025; 5306-5316. doi: 10.1158/1078-0432.CCR-25-1796

Bernard E, Cortés-Ciriano I, Gaiti F, Gan S, Jiang S, Kovatcheva M, Meisel M, Reticker-Flynn NE, Schram AM, Shoshani O, Silverbush D, Venkataramani V, Weeden CE, Zhou X

Reflections on Advances in Cancer Research in 2025.

Cancer Discov 2025; 2422-2430. doi: 10.1158/2159-8290.CD-25-1833

Modafferi S, Farina S, Esposito F, Brandi O, Di Salvio M, Della Valle I, D'Uva S, Scarian E, Cicio G, Riccardi A, Pisati F, Garbelli A, Santini T, Pansarasa O, Morlando M, D'Ambrosi N, Cozzolino M, Cestra G, d'Adda di Fagagna F, Gioia U, Francia S

DNA damage response defects induced by the formation of TDP-43 and mutant FUS cytoplasmic inclusions and their pharmacological rescue.

Cell Death Differ 2025; 2309-2322. doi: 10.1038/s41418-025-01530-7

Amatu A, Patelli G, Zampino MG, Bergamo F, Mosconi S, Tosi F, Ciardiello D, Lonardi S, Negrini G, Sibio D, Gerardi MA, Galuppo S, Filippone FR, Carnevali P, Borin S, Pilati P, Poiasina E, Bonazzina E, Gervaso L, Mammano E, Bracco F, Bergamaschi L, Spolverato G, Origi M, Romario UF, Mauri G, Fazio N, Forti E, De Roberto G, Cristofori C, Burti C, Asmundo L, Funicelli L, Ramondo G, Bonaffini PA, Mariano S, Lazzari L, Ghezzi S, Isella C, Cantarella D, Aquilano MC, Bottiglieri L, Bonoldi E, Mutignani M, Torri V, Medico E, Bardelli A, Marsoni S, Vanzulli A, Palazzi MF, Ferrari GC, Bencardino K, Sartore-Bianchi A, Siena S

Total neoadjuvant therapy followed by non-operative management or surgery in stage II-III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial.

Lancet Oncol 2025; 1612-1625. doi: 10.1016/S1470-2045(25)00542-X

Eli S, Rauso G, Ghezzi P, Szczerkowski JLA, Bruzzi M, Rizzelli F, Iommazzo F, Loffreda A, Castagna F, Donà F, Gaddoni C, Dondi A, Marenda M, Rodighiero S, Tournier P, Lavagnino Z, Parazzoli D, Gauthier NC, Tamburri S, Pasini D, Habib SJ, Mapelli M

Localized Wnt-signaling promotes asymmetric NuMA-dependent oriented divisions and unequal apportioning of mitochondria.

Nat Commun 2025; 10690. doi: 10.1038/s41467-025-65775-z

Lauriola A, Enriqué Steinberg JH, Sarubo M, Maspero E, Rossi FA, Mouri Y, Pedretti M, Hajisadeghian M, Taibi V, Vettori A, Vitulo N, Assfalg M, D'Onofrio M, Rossi M, Yasue A, Astegno A, Polo S, Santi S, Kudo Y, Guardavaccaro D

The E3 ligase RNF32 controls the IκB kinase complex and NF-κB signaling in intestinal stem cells.

Mol Cell 2025; 4254-4267.e9. doi: 10.1016/j.molcel.2025.10.005

Sepe S, Rey F, Mancheno-Ferris A, Bigi A, Fani G, Damiani D, Cabrini M, Marinelli E, Aguado J, Contu L, di Lillo A, Boggio S, Tavella S, Rosso I, Gustincich S, Chiti F, d'Adda di Fagagna F

Telomeric DNA damage response mediates neurotoxicity of Aβ42 oligomers in Alzheimer's disease.

EMBO J 2025; 6078-6111. doi: 10.1038/s44318-025-00521-1

Carter RD, Purnama U, Castro-Guarda M, Montes-Aparicio CN, Chandran A, Mbasu R, Ruby M, Daly C, Brisk K, Christian HC, Miller JJJJ, Buffa FM, Heather LC, Carr CA

Systems Biology and Functional Assessments of Human iPSC-Cardiomyocyte Models of Insulin Resistance Capture Key Hallmarks of Diabetic Cardiomyopathy.

Diabetes 2025; 1929-1945. doi: 10.2337/db25-0204

Blondeaux E, Delucchi V, Mariamidze E, Bernstein-Molho R, Frank S, Ferrari A, Linn S, Kim HJ, Agostinetto E, Paluch-Shimon S, Cortesi L, Di Meglio A, Balmana J, Yerushalmi R, Rodriguez-Wallberg KA, Renaud T, Cui W, Moore HCF, Wong SM, Pogoda K, Lustberg M, Phillips KA, Han S, Puglisi F, Vernieri C, Bajpai J, Sonnenblick A, Rousset-Jablonski C, De Marchis L, De Giorgi U, Bianchini G, Texeira L, Duhoux FP, Villarreal-Garza C, Sini V, Fruscio R, Del Mastro L, Demeestere I, Azim HA, Peccatori FA, Partridge AH, Lambertini M

Breastfeeding after breast cancer in young BRCA carriers.

J Natl Cancer Inst 2025; 2229-2239. doi: 10.1093/jnci/djaf177

Toli MA, Liu X, Massa D, Lando S, Boman C, Tsiknakis N, Tranchell C, Papakonstantinou A, Fotia G, Vernieri C, Guarneri V, Bergh J, Dieci MV, Bergman LE, Matikas A, Foukakis T

Prognostic significance of tumour Ki-67 dynamics during neoadjuvant treatment in patients with breast cancer: a population-based cohort study.

Lancet Reg Health Eur 2025; 101432. doi: 10.1016/j.lanepe.2025.101432

Buonaiuto R, Fordellone M, Caltavituro A, Cataldo ML, Criscitiello C, Dieci MV, Lambertini M, Botticelli A, Giuliano M, Giordano A, Mangiacotti F, Grieco A, Longobardi A, Caputo R, Pagliuca M, Vernieri C, Malorni L, Gerratana L, Arpino G, Chiodini P, De Laurentiis M, De Angelis C

Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2- metastatic breast cancer: a systematic review and network meta-analysis.

EClinicalMedicine 2025; 103535. doi: 10.1016/j.eclinm.2025.103535

Ponzo M, Drufuca L, Buracchi C, Sindoni MM, Nucera S, Bugarin C, Bason R, Rossetti G, Bonnal R, Meli C, Rambaldi B, Lussana F, Ferrari S, Moretti A, Dastoli G, Risca G, Pellegrino C, Manz MG, Galimberti S, Rambaldi A, Gaipa G, Biondi A, Pagani M, Magnani CF

Acquisition of an immunosuppressive microenvironment after anti-CD19 CAR T-cell therapy is associated with T-cell dysfunction and resistance.

J Immunother Cancer 2025; . doi: 10.1136/jitc-2025-011768

%PLACEHOLDER%